κ-Opioid Receptor Agonist U50448H Protects Against Acute Lung Injury in Rats with Cardiopulmonary Bypass via the CAP-NLRP3 Signaling Pathway.

Gao GJ, Song DD, Li L, Zhao F, Sun YJ

Open source

DOI
10.1155/2022/2868135
Published
2022
Container
Evidence-based complementary and alternative medicine : eCAM
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/2868135,
  title = {κ-Opioid Receptor Agonist U50448H Protects Against Acute Lung Injury in Rats with Cardiopulmonary Bypass via the CAP-NLRP3 Signaling Pathway.},
  author = {Gao GJ and Song DD and Li L and Zhao F and Sun YJ},
  year = {2022},
  journal = {Evidence-based complementary and alternative medicine : eCAM},
  doi = {10.1155/2022/2868135},
  url = {https://doi.org/10.1155/2022/2868135}
}

RIS

TY  - JOUR
TI  - κ-Opioid Receptor Agonist U50448H Protects Against Acute Lung Injury in Rats with Cardiopulmonary Bypass via the CAP-NLRP3 Signaling Pathway.
AU  - Gao GJ
AU  - Song DD
AU  - Li L
AU  - Zhao F
AU  - Sun YJ
PY  - 2022
JO  - Evidence-based complementary and alternative medicine : eCAM
DO  - 10.1155/2022/2868135
UR  - https://doi.org/10.1155/2022/2868135
ER  - 

APA

GJ, G., DD, S., L, L., F, Z., & YJ, S. (2022). κ-Opioid Receptor Agonist U50448H Protects Against Acute Lung Injury in Rats with Cardiopulmonary Bypass via the CAP-NLRP3 Signaling Pathway.. Evidence-based complementary and alternative medicine : eCAM. https://doi.org/10.1155/2022/2868135

Source records